Mucormycosis: Literature review and retrospective report of 15 cases from Portugal
| Autor: | Lurdes Santos, Beatriz Prista-Leão, A. Sarmento, Isabel Gomes Abreu, Ana Cláudia Carvalho |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
QH301-705.5 medicine.medical_treatment Population Microbiology mucormycosis Diabetes mellitus Medicine Biology (General) education Intensive care medicine Internal medicine education.field_of_study immunosuppression invasive fungal infections medicine.diagnostic_test business.industry Mucormycosis Immunosuppression Retrospective cohort study medicine.disease RC31-1245 Infectious Diseases Therapeutic drug monitoring Infectious diseases department Original Article Histopathology business |
| Zdroj: | Current Medical Mycology, Vol 6, Iss 4, Pp 47-53 (2020) Current Medical Mycology |
| ISSN: | 2423-3420 2423-3439 |
| Popis: | Background and Purpose: Prevalence of mucormycosis is growing with the increase of the population at risk. Current recommendations for its management are mostly based on retrospective studies. 3 study aimed to present the cumulative experience of an Infectious Diseases Department from a Portuguese hospital in the management of mucormycosis and discuss the potential gaps in the diagnostic and therapeutic approaches of this infection. Materials and Methods: For the purposes of the study, the electronic hospital database was searched for adult patients with mucormycosis from 1996 to 2019 based on the definition provided by the Consensus Definitions of Invasive Fungal Disease. Demographic, clinical, treatment, and outcome data were collected and compared to what had been described in the related literature. Results: In total, 15 cases of mucormycosis were found, including 11 cases with sinus involvement (10 with central nervous system involvement), two pulmonary, and two gastrointestinal infections. Diabetes mellitus (n=7) and corticosteroid therapy (n=7) were frequent risk factors. Median duration of symptoms before the suspicion of diagnosis was 26 days (3-158). The diagnosis was confirmed in 12 patients mostly by histopathology (n=9); the culture was positive only once. Systemic antifungals and surgical debridement were the backbones of treatment; however, side effects, the need for therapeutic drug monitoring, and the anatomical location of lesions added complexity to management. Overall, seven patients died, two of them before the consideration of clinical suspicion. Conclusion: More medications are becoming available for the treatment of mucormycosis. Nevertheless, we believe that its prognosis will only significantly change through the increase of awareness and reduction of the time to diagnosis. An effective multidisciplinary approach among surgeons, infectious diseases specialists, radiologists, microbiologists, and anatomopathologists is critical to the achievement of this goal. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|